Unwinding the Collagen Fibrils: Elucidating the Mechanism of Pirfenidone and Nintedanib in Pulmonary Fibrosis

被引：12
作者：
Bahudhanapati, Harinath [1 ]
Kass, Daniel J. [1 ]
机构：
[1] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 2017年 / 57卷 / 01期
关键词：
EFFICACY; PLACEBO; TRIAL;
D O I：
10.1165/rcmb.2017-0079ED
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：10 / 11
页数：2
相关论文
共 14 条
[1]  
[Anonymous], 2014, NY TIMES
[2]   COUNTERPOINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? No [J].
Brown, Kevin K. .
CHEST, 2016, 150 (02) :276-278
[3]   Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis [J].
Chaudhary, N. I. ;
Roth, G. J. ;
Hilberg, F. ;
Mueller-Ouernheim, J. ;
Prasse, A. ;
Zissel, G. ;
Schnapp, A. ;
Park, J. E. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (05) :976-985
[4]   Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts [J].
Conte, Enrico ;
Gili, Elisa ;
Fagone, Evelina ;
Fruciano, Mary ;
Iemmolo, Maria ;
Vancheri, Carlo .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 58 :13-19
[5]   Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results [J].
Daniels, Craig E. ;
Lasky, Joseph A. ;
Limper, Andrew H. ;
Mieras, Kathleen ;
Gabor, Edith ;
Schroeder, Darrell R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (06) :604-610
[6]   Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors [J].
Didiasova, Miroslava ;
Singh, Rajeev ;
Wilhelm, Jochen ;
Kwapiszewska, Grazyna ;
Wujak, Lukasz ;
Zakrzewicz, Dariusz ;
Schaefer, Liliana ;
Markart, Philipp ;
Seeger, Werner ;
Lauth, Matthias ;
Wygrecka, Malgorzata .
FASEB JOURNAL, 2017, 31 (05) :1916-1928
[7]   Idiopathic pulmonary fibrosis [J].
King, Talmadge E., Jr. ;
Pardo, Annie ;
Selman, Moises .
LANCET, 2011, 378 (9807) :1949-1961
[8]   A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone [J].
Knueppel, Larissa ;
Ishikawa, Yoshihiro ;
Aichler, Michaela ;
Heinzelmann, Katharina ;
Hatz, Rudolf ;
Behr, Juergen ;
Walch, Axel ;
Baechinger, Hans Peter ;
Eickelberg, Oliver ;
Staab-Weijnitz, Claudia A. .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 57 (01) :77-90
[9]   The integrin αvβ6 binds and activates latent TGFβ1:: A mechanism for regulating pulmonary inflammation and fibrosis [J].
Munger, JS ;
Huang, XZ ;
Kawakatsu, H ;
Griffiths, MJD ;
Dalton, SL ;
Wu, JF ;
Pittet, JF ;
Kaminski, N ;
Garat, C ;
Matthay, MA ;
Rifkin, DB ;
Sheppard, D .
CELL, 1999, 96 (03) :319-328
[10]   A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level [J].
Nakazato, H ;
Oku, H ;
Yamane, S ;
Tsuruta, Y ;
Suzuki, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 446 (1-3) :177-185
12